We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
First Proton Treatments with RayStation and MEVION S250
Product News

First Proton Treatments with RayStation and MEVION S250

First Proton Treatments with RayStation and MEVION S250
Product News

First Proton Treatments with RayStation and MEVION S250


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "First Proton Treatments with RayStation and MEVION S250"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

On April 30, 2015 a major milestone was reached at Ackerman Cancer Center in Jacksonville, Florida when the first patient was treated with the MEVION S250 and the RayStation® Treatment Planning System. Ackerman Cancer Center is the first private, physician-owned practice to implement proton therapy.

The clinical patient treatment plans were created entirely in RayStation®, RaySearch’s highly advanced treatment planning and dose tracking software platform, and delivered on the MEVION S250 Proton System. “Providing this kind of innovative technology in a private setting is something that we knew we could accomplish. We look forward to working with our partners, RaySearch and Mevion, well into the future to bring cutting edge treatments to our patients,” said Scot Ackerman, M.D., Medical Director of the Center.

“The implementation of proton therapy in a private center really shows how far this technology has come and how accessible it can be,” says Marc Mlyn, President of RaySearch Americas, Inc. “We are pleased that the Mevion and RaySearch combined solution has led to such a successful effort so rapidly, and we are glad to be partners with Ackerman Cancer Center’s team of professionals.”

“While we have many clinical proton sites in the USA, Europe and soon Asia, it is very satisfying to see the first Mevion and RaySearch effort up and running. RayStation was developed to handle any type of delivery system, and we will continue to work in close collaboration with our partners to bring new and exciting technologies to our mutual customers”, says Johan Löf, CEO of RaySearch Laboratories AB.

The current version of RayStation® supports all relevant proton treatment techniques such as Uniform Scanning, Double Scattering and PBS / IMPT.

Advertisement